| 000 | 01495 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518033217.0 | ||
| 264 | 0 | _c20190624 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2150-7511 | ||
| 024 | 7 |
_a10.1128/mBio.00226-19 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiang, Shasha | |
| 245 | 0 | 0 |
_aAntibacterial Properties and Efficacy of a Novel SPLUNC1-Derived Antimicrobial Peptide, α4-Short, in a Murine Model of Respiratory Infection. _h[electronic resource] |
| 260 |
_bmBio _c04 2019 |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xisolation & purification |
| 650 | 0 | 4 |
_aAntimicrobial Cationic Peptides _xisolation & purification |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 |
_aBiological Products _xisolation & purification |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aMicrobial Viability _xdrug effects |
| 650 | 0 | 4 |
_aPhosphoproteins _xmetabolism |
| 650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
| 650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDeslouches, Berthony | |
| 700 | 1 | _aChen, Chen | |
| 700 | 1 | _aDi, Matthew E | |
| 700 | 1 | _aDi, Y Peter | |
| 773 | 0 |
_tmBio _gvol. 10 _gno. 2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/mBio.00226-19 _zAvailable from publisher's website |
| 999 |
_c29571652 _d29571652 |
||